Back
Recursion Pharmaceuticals Stock Predictions
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
RXRX
Recursion Pharmaceuticals
Last Price:
6.81
Seasonality Move:
-13.67%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Recursion Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 34.2% based on the past 3 years of stock performance.
- Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Recursion Pharmaceuticals Stock Undervalued?
The current Recursion Pharmaceuticals [RXRX] share price is $6.93. The Score for RXRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Recursion Pharmaceuticals has on average historically fallen by 34.2% based on the past 3 years of stock performance.
Recursion Pharmaceuticals Stock Rating
Sell
46
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals overpriced?
- Recursion Pharmaceuticals has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
15.74
52-Week Low:
4.97
Prediction Charts
Market Cap:
1.96B
Price in USD:
6.93
Volume:
4.02M
Beta:
0.82
Technical Analysis
SMA50:
7.19
SMA100:
7.95
SMA200:
9.05
52-Wk Change:
-17.89%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?
Yes, Recursion Pharmaceuticals is a publicly traded company. -
What is the Recursion Pharmaceuticals stock quote today?
The Recursion Pharmaceuticals stock price is 6.93 USD today. -
How to buy Recursion Pharmaceuticals stock online?
You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-30 | 7.53 | 7.27 | 7.60 | 7.20 |
| Sep-3 | 6.46 | 6.07 | 6.78 | 5.94 |
| Sep-4 | 6.05 | 6.10 | 6.23 | 5.89 |
| Sep-5 | 6.14 | 6.17 | 6.33 | 6.04 |
| Sep-6 | 6.16 | 5.92 | 6.30 | 5.90 |
| Sep-9 | 5.95 | 6.12 | 6.13 | 5.91 |
| Sep-10 | 6.16 | 6.32 | 6.32 | 6.06 |
| Sep-11 | 6.18 | 6.45 | 6.51 | 6.17 |
| Sep-12 | 6.44 | 6.50 | 6.64 | 6.25 |
| Sep-13 | 6.60 | 6.57 | 6.76 | 6.44 |
| Sep-16 | 6.56 | 6.65 | 6.67 | 6.40 |
| Sep-17 | 6.73 | 6.76 | 7.04 | 6.73 |
| Sep-18 | 6.81 | 6.90 | 7.41 | 6.81 |
| Sep-19 | 7.16 | 6.93 | 7.24 | 6.90 |
Recursion Pharmaceuticals Earnings
Recursion Pharmaceuticals Earnings Report: Per Share Recursion Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Recursion Pharmaceuticals Forecast Revenue Growth
Recursion Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Recursion Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.